A Novel Form of Familial Vasopressin Deficient Diabetes Insipidus Transmitted in an X-linked Recessive Manner

Reema Habiby, Daniel G. Bichet, Marie Francoise Arthus, Dervia Connaughton, Shirlee Shril, Shrikant Mane, Amar J. Majmundar, Friedhelm Hildebrandt, Gary L. Robertson*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Context: Familial pituitary diabetes insipidus has been described only in an autosomal dominant or recessive mode of inheritance. Objective: This work aims to determine the cause of a novel form of familial diabetes insipidus (DI) that is controlled by desmopressin therapy but segregates in an X-linked recessive manner. Methods: Thirteen members from 3 generations of the kindred with familial DI were studied. Water intake, urine volume, urine osmolality, plasma osmolality, and plasma vasopressin were measured under basal conditions, during fluid deprivation, 3% saline infusion, and water loading. Magnetic resonance images of the posterior pituitary also were obtained. In affected males, the effects of desmopressin therapy and linkage of the DI to markers for chromosome Xq28 were determined. In addition, the genes encoding vasopressin, aquaporin-2, the AVPR2 receptor, and its flanking regions were sequenced. Results: This study showed that 4 males from 3 generations of the kindred have DI that is due to a deficiency of vasopressin, is corrected by standard doses of desmopressin, and segregates with markers for the AVPR2 gene in Xq28. However, no mutations were found in AVPR2 or its highly conserved flanking regions. Exome sequencing confirmed these findings and also revealed no deleterious variants in the provasopressin and aquaporin-2 genes. The 4 obligate female carriers osmo-regulated vasopressin in the low normal range. Conclusion: X-linked recessive transmission of DI can be due to a defect in either the secretion or the action of vasopressin. Other criteria are necessary to differentiate and manage the 2 disorders correctly.

Original languageEnglish (US)
Pages (from-to)E2513-E2522
JournalJournal of clinical endocrinology and metabolism
Volume107
Issue number6
DOIs
StatePublished - Jun 1 2022

Funding

The clinical studies in this work were supported by the National Institutes of Health (NIH GCRC grant No. 2MO1RR000048-32). The exome sequencing was supported by the NIH (grant No. 5RO1DK068306-16 to F.H.) A.J.M. was supported by the NIH (training grant No. T32DK- 007726), a 2017 Post-Doctoral Fellowship Grant from the Harvard Stem Cell Institute, and the American Society of Nephrology Lipps Research Program 2018 Polycystic Kidney Disease Foundation Jared J Grantham Research Fellowship. D.M.C. was funded by Health Research Board, Ireland (HPF- 206-674), the International Pediatric Research Foundation Early Investigators' Exchange Program, and the Amgen Irish Nephrology Specialist Registrar Bursary. She is also funded by the Eugene Drewio Chair for Kidney Research and Innovation at the Schulich School of Medicine & Dentistry at Western University London, Ontario, Canada. The Yale Center for Mendelian Genomics (No. UM1HG006504) is funded by the National Human Genome Research Institute. The GSP Coordinating Center (No. U24 HG008956) contributed to cross-program scientific initiatives and provided logistical and general study coordination.

Keywords

  • X-linked transmission
  • diabetes insipidus
  • vasopressin deficiency

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint

Dive into the research topics of 'A Novel Form of Familial Vasopressin Deficient Diabetes Insipidus Transmitted in an X-linked Recessive Manner'. Together they form a unique fingerprint.

Cite this